Mei, Davide Antonio
 Distribuzione geografica
Continente #
AS - Asia 3.205
NA - Nord America 1.899
EU - Europa 1.279
SA - Sud America 474
AF - Africa 62
OC - Oceania 8
Totale 6.927
Nazione #
US - Stati Uniti d'America 1.813
SG - Singapore 1.109
CN - Cina 967
IT - Italia 515
VN - Vietnam 356
BR - Brasile 342
HK - Hong Kong 291
KR - Corea 164
FI - Finlandia 160
GB - Regno Unito 126
DE - Germania 107
RU - Federazione Russa 96
FR - Francia 76
AR - Argentina 57
ID - Indonesia 52
NL - Olanda 39
IN - India 37
MX - Messico 34
CA - Canada 31
BD - Bangladesh 29
SE - Svezia 26
TR - Turchia 23
ES - Italia 22
PL - Polonia 20
UZ - Uzbekistan 19
AT - Austria 17
CO - Colombia 17
PK - Pakistan 17
IQ - Iraq 16
JP - Giappone 16
AE - Emirati Arabi Uniti 15
EC - Ecuador 15
ZA - Sudafrica 15
CL - Cile 14
UA - Ucraina 14
TW - Taiwan 13
LT - Lituania 12
SA - Arabia Saudita 12
EG - Egitto 10
VE - Venezuela 10
BE - Belgio 9
MA - Marocco 9
TH - Thailandia 9
AU - Australia 7
AZ - Azerbaigian 7
KE - Kenya 7
TN - Tunisia 7
GE - Georgia 6
KZ - Kazakistan 6
BO - Bolivia 5
CU - Cuba 5
DZ - Algeria 5
IL - Israele 5
JO - Giordania 5
OM - Oman 5
PE - Perù 5
PT - Portogallo 5
PY - Paraguay 5
BG - Bulgaria 4
IE - Irlanda 4
PH - Filippine 4
RO - Romania 4
SV - El Salvador 4
UY - Uruguay 4
CZ - Repubblica Ceca 3
HU - Ungheria 3
JM - Giamaica 3
MY - Malesia 3
NP - Nepal 3
RS - Serbia 3
AL - Albania 2
AM - Armenia 2
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
CR - Costa Rica 2
CY - Cipro 2
KG - Kirghizistan 2
PA - Panama 2
PS - Palestinian Territory 2
SN - Senegal 2
AO - Angola 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IR - Iran 1
KH - Cambogia 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
Totale 6.918
Città #
Singapore 697
Hefei 500
Santa Clara 338
Ashburn 307
Hong Kong 288
San Jose 244
Seoul 164
Beijing 124
Ho Chi Minh City 117
Helsinki 110
Hanoi 87
London 78
New York 62
Los Angeles 59
Chicago 57
The Dalles 57
Milan 48
Lauterbourg 46
Bologna 45
Council Bluffs 44
Munich 42
São Paulo 37
Jakarta 36
Lappeenranta 36
Dallas 34
Buffalo 31
Rome 30
Kent 29
Moscow 29
Salt Lake City 25
Frankfurt am Main 23
Orem 23
Shanghai 23
Modena 22
Mexico City 21
Amsterdam 18
Da Nang 17
Tashkent 17
Haiphong 16
Portsmouth 15
Nuremberg 14
Warsaw 14
Chandler 13
Nyköping 13
Turku 13
Fairfield 12
Naples 12
Tokyo 12
Curitiba 11
Rio de Janeiro 11
Boardman 10
Chennai 10
Düsseldorf 10
Paris 10
Santiago 10
Stockholm 10
Tampa 10
Hangzhou 9
Istanbul 9
Miami 9
Montreal 9
Salvador 9
Seattle 9
Atlanta 8
Campinas 8
Elk Grove Village 8
Manchester 8
Turin 8
Vienna 8
Biên Hòa 7
Brooklyn 7
Brussels 7
Carpi 7
Fortaleza 7
Hải Dương 7
Parma 7
Phoenix 7
Redondo Beach 7
Bari 6
Brescia 6
Bắc Ninh 6
Calgary 6
Ferrara 6
Ha Long 6
Hillsboro 6
Madrid 6
Mumbai 6
Nairobi 6
Quito 6
Reggio Emilia 6
Tbilisi 6
Vigasio 6
Belo Horizonte 5
Bến Tre 5
Can Tho 5
Columbus 5
Dhaka 5
Harbin 5
Havana 5
Houston 5
Totale 4.480
Nome #
2022 ESC Guidelines for the management of ventricular arrhythmias and sudden cardiac death: an important focus on a multidisciplinary approach to a tailored diagnostic and therapeutic work-up|Linee guida europee 2022 su aritmie ventricolari e morte cardiaca improvvisa: un importante impulso a un impegno multidisciplinare in campo diagnostico e terapeutico per un’accurata personalizzazione dell’approccio clinico 250
Asymptomatic vs. symptomatic atrial fibrillation: Clinical outcomes in heart failure patients 236
DIGItal Health Literacy after COVID-19 Outbreak among Frail and Non-Frail Cardiology Patients: The DIGI-COVID Study 229
Comparative analysis of level of evidence and class of recommendation for 50 clinical practice guidelines released by the European Society of Cardiology from 2011 to 2022 213
Remote monitoring and telemedicine in heart failure: implementation and benefits 213
Atrial cardiomyopathy: An entity of emerging interest in the clinical setting 208
The 2024 ESC guidelines on atrial fibrillation: essential updates for everyday clinical practice 188
Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials? 187
Low Occurrence of Infections and Death in a Real-World Cohort of Patients with Cardiac Implantable Electronic Devices 174
Single-lead VDD pacing: a literature review on short-term and long-term performance 172
Cardiac Surgery in Jehovah's Witnesses Patients and Association With Peri-Operative Outcomes: A Systematic Review and Meta-Analysis 170
Cardiovascular Reasons for Access to a Tertiary Oncological Emergency Service: The CARILLON Study 158
Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients 153
Cardiac resynchronization therapy (CRT) nonresponders in the contemporary era: A state-of-the-art review 152
Features of Clinical Complexity in European Patients With Atrial Fibrillation: A Report From a European Observational Prospective AF Registry 151
Atrial fibrillation in vascular surgery: a systematic review and meta-analysis on prevalence, incidence and outcome implications 150
Association of comorbidity patterns with outcomes and relation with the ABC pathway effectiveness in European patients with atrial fibrillation 149
Remote multiparametric monitoring and management of heart failure patients through cardiac implantable electronic devices 147
Quantification of Myocardial Contraction Fraction with Three-Dimensional Automated, Machine-Learning-Based Left-Heart-Chamber Metrics: Diagnostic Utility in Hypertrophic Phenotypes and Normal Ejection Fraction 146
Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations 146
Systematic review and meta-Analysis on the impact on outcomes of device algorithms for minimizing right ventricular pacing 144
Clinical decisions for appropriate management of patients with atrial fibrillation 141
Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry 138
Atrial Fibrillation Ablation in Patients Recently Hospitalized for Worsening Heart Failure: Need for Individualized Decision-Making 137
Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices: Dynamic Changes in Episodes and Predictors of Incident Atrial Fibrillation 133
Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry 125
Impact of chronic obstructive pulmonary disease in patients with atrial fibrillation: An analysis from the GLORIA-AF registry 124
Atrial fibrillation, comorbidities, stroke, and mortality in real‑world clinical practice 120
CHA2DS2-VA instead of CHA2DS2-VASc for stroke risk stratification in patients with atrial fibrillation: not just a matter of sex 117
Clinical Outcomes in Metabolically Healthy and Unhealthy Obese and Overweight Patients With Atrial Fibrillation: Findings From the GLORIA-AF Registry 112
Therapeutic effects of sodium–glucose cotransporter 2 inhibitors in patients with heart failure with preserved ejection fraction: From outcome improvement to potentially favourable influences on atrial fibrillation burden, atrial fibrillation progression and atrial cardiomyopathy 111
Antiarrhythmic drugs in the era of atrial fibrillation ablation 109
Prepare our healthcare systems to manage complexity: the case of atrial fibrillation 109
Left and right atrial echocardiographic parameters and outcome in patients with atrial fibrillation 106
Multimorbidity in atrial fibrillation: A call for integrated patient-centered care 104
Provision of care in clinical cardiac electrophysiology during and after the COVID-19 pandemic: An open challenge for health care systems 97
Detection and management of postoperative atrial fibrillation after coronary artery bypass grafting or non-cardiac surgery: a survey by the AF-SCREEN International Collaboration 95
Atrial fibrillation screening: The importance of the patient perspective 88
Peripheral artery disease, antithrombotic treatment and outcomes in European and Asian patients with atrial fibrillation: analysis from two prospective observational registries 84
Patterns of comorbidities in patients with atrial fibrillation and impact on management and long-term prognosis: an analysis from the Prospective Global GLORIA-AF Registry 78
Atrial fibrillation and female sex: use of oral anticoagulants in a large European cohort and residual risk of thromboembolism and stroke 69
Economic Evaluations in Electrophysiology in the Last 15 Years: A Systematic Review of the Literature 67
Cardiovascular-kidney-metabolic domains and impact on antithrombotic treatment, integrated care and clinical outcomes in patients with atrial fibrillation: results from a prospective European registry 66
Mobile/wearable digital devices for care of active cancer patients: a survey from the ESC Council of Cardio-Oncology 66
Real-World Use of ARNI Within GDMT in HFrEF Patients with and Without Atrial Fibrillation: A Retrospective Analysis of Cardiac and Renal Functions and Clinical Outcomes 66
Chronic kidney disease classification according to different formulas and impact on adverse outcomes in patients with atrial fibrillation: A report from a prospective observational European registry 62
Flecainide and atrial fibrillation cardioversion: what solutions at present and in the near future? 56
Physical activity in patients with atrial fibrillation and adverse outcomes: results from a large-scale prospective multicenter European cohort 53
Efficacy of the ABC Pathway for Integrated Care Across Phenotypes of Patients with Atrial Fibrillation: A Latent-Class Analysis Report from the mAFA-II Clinical Trial 49
Educational status affects prognosis of patients with heart failure with reduced ejection fraction: A post‐hoc analysis from the WARCEF trial 47
Personalized clinical management of patients with atrial fibrillation: is a biomarker-based strategy for prediction of sinus rhythm persistence ready for prime time? 46
Subclinical atrial fibrillation/atrial high-rate episodes: what significance and decision-making? 45
Cardio-kidney-metabolic complexity in patients with atrial fibrillation: an analysis from the prospective GLORIA-AF registry phase III 45
Female sex as risk factor for undertreatment: need for a paradigm shift in the care of atrial fibrillation and ischaemic disease 43
Antiarrhythmic drugs and ablation in patients with atrial fibrillation: New perspectives 42
Sex-related differences in presentation, treatment, and outcomes of Asian patients with atrial fibrillation: a report from the prospective APHRS-AF Registry 41
Atrial fibrillation ablation in the perspective of holistic patient-centred care: all-cause mortality as an outcome of reference at long-term 41
Stroke prevention in atrial fibrillation patients with end-stage renal disease: how far from Ithaca after a long Odyssey? 38
A European-Multicenter Network for the Implementation of Artificial Intelligence to Manage Complexity and Comorbidities of Atrial Fibrillation Patients: The ARISTOTELES Consortium 38
Artificial intelligence in patients with atrial fibrillation to manage clinical complexity and comorbidities: the ARISTOTELES project 37
Multimorbidity, frailty and polypharmacy in European and Asian patients with atrial fibrillation: a comparison of two regional prospective observational registries 36
Cost-consequence analysis of three cardiac ablation technologies in paroxysmal atrial fibrillation 34
From fixed time points to personalized care: rethinking stroke risk management in atrial fibrillation patients 24
The intriguing relationships between atrial fibrillation and heart failure: insights from cardiac implantable electronic devices 23
Totale 6.998
Categoria #
all - tutte 27.472
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.472


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202244 13 2 1 0 2 6 0 0 1 3 6 10
2022/2023110 7 6 8 7 5 5 4 12 15 6 27 8
2023/2024427 5 18 26 52 109 47 39 44 9 15 20 43
2024/20251.783 24 12 17 76 205 282 168 139 186 131 292 251
2025/20264.634 342 233 378 662 600 233 693 306 629 490 68 0
Totale 6.998